It's hoped a first-of-its-kind computer model of nasal cavity will help develop treatments for diseases like Parkinsons and Alzheimers.
Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback